HCC vs. LC: 95%/86%, AUC 0.93 (no improvement with addition of AFP)HCC vs. healthy: 95%/95%Sensitivity based on cancer stage: 75% (BCLC stage 0), 93% (A/B), 100% (C/D). This evidence concerns the gene AFP and hepatocellular carcinoma.